Loading clinical trials...
Loading clinical trials...
A Phase I Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
Conditions
Interventions
MLN9708
Nelfinavir
Locations
1
United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Start Date
August 1, 2016
Primary Completion Date
August 4, 2017
Completion Date
August 4, 2017
Last Updated
February 6, 2018
NCT00026884
NCT05139017
NCT07169851
NCT07213804
NCT06263491
NCT06337318
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions